help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0354
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garone, L. M.
Right arrow Articles by McKenna, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garone, L. M.
Right arrow Articles by McKenna, S.
Endocrinology Vol. 147, No. 9 4205-4212
Copyright © 2006 by The Endocrine Society

Biological Properties of a Novel Follicle-Stimulating Hormone/Human Chorionic Gonadotropin Chimeric Gonadotropin

Louise M. Garone, Elena Ammannati, Theresa S. Brush, David J. Fischer, Enrico Gillio Tos, Jiangping Luo, Kimberley L. Altobello, Cinzia Ciampolillo, Thomas M. Ihley, Emmi Kurosawa, Angela Tiebout and Sean McKenna

Serono Research Institute, Inc. (L.M.G., T.S.B., D.J.F., J.L., K.L.A., T.M.I., E.K., A.T., S.M.), Rockland, Massachusetts 02370; Istituto di Ricerche Biomediche "Antoine Marxer" (E.A., E.G.T., C.C.), 10010 Colleretto Giacosa, Torino, Italy

Address all correspondence and requests for reprints to: Louise M. Garone, Serono Research Institute, One Technology Place, Rockland Massachusetts 02370. E-mail: louise.garone{at}serono.com.

A chimeric recombinant human gonadotropin, termed C3, demonstrates both follitropic and lutropic bioactivities. The {alpha}-subunit construct for C3 is comprised of the recombinant wild-type human glycoprotein hormone {alpha}-subunit. The ß-subunit DNA construct for C3 encodes residues 1–145 from human chorionic gonadotropin (hCG)-ß with the exceptions that FSHß amino acid 88 (D) is substituted for hCGß amino acid 94 (R) and FSHß amino acids 95–108 (TVRGLGPSYCSFGE) are substituted for hCGß amino acids 101–114 (GGPKDHPLTCDDPR). C3 is a potent FSH and LH agonist able to bind and to signal through FSH and LH receptors in vitro. In in vivo bioassays optimized to quantify each type of activity, C3 was found to have lutropin and follitropin potencies at levels similar to those of recombinant human LH and recombinant human FSH, respectively. In immature rats, C3 was sufficient to support the maturation of normal ovarian follicles. Moreover, a significant portion of follicles matured by C3 ruptured in response to an ovulatory hCG stimulus and gave rise to morphologically normal oocytes. Furthermore, a low dose of C3 promoted weight gain in the rodent uterus, suggesting it also supported preparation for implantation without histological evidence of excessive luteinization of the ovary. In summary, the biological properties of C3 indicate that its chimeric nature has resulted in a fully functional, dual-acting human gonadotropin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society